United States · Venture startup
4 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Vitae Pharmaceuticals and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$79Mraised across 4 rounds since 2004, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $15M sold, first sale Jun 2009
From a historical funding record
From a historical funding record
Vitae Pharmaceuticals filed one raise, $15M in all. Filings say how much was sold and to how many investors; they never name the investors.
From the SEC filings it signed: 3 on the team.
On the board, as filediBryan RobertsCharles NewhallDonald HaydenJames TananbaumPeter BarrettRobert Gunderson
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Venrock
New Enterprise Associates
Prospect Venture Partners
Intel Capital
Atlas Venture
Wellcome TrustMissing a round, or an investor who was in one? Tell us.
Vitae Pharmaceuticals's investors include Venrock, New Enterprise Associates, Prospect Venture Partners, Intel Capital and Atlas Venture, and 1 more on record.
Vitae Pharmaceuticals has raised $79M across 4 rounds since 2004.
Vitae Pharmaceuticals's most recent round was a Venture of $15M in Jun 2009.
Vitae Pharmaceuticals's largest round on record is $34M (Series B), in Jan 2005.
Vitae Pharmaceuticals's first round on record, in Jan 2004, was backed by New Enterprise Associates, Intel Capital and Venrock and 1 others.
Vitae Pharmaceuticals's latest named round is a Venture, in Jun 2009.
Vitae Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
